Search Tag: heart failure
2023 20 Apr
Vasopressors and inotropes are frequently used in intensive care units. With a special focus on recent studies, this article summarises the key messages in the management of patients requiring inotropes and vasopressors. Introduction Cardiac output (CO) is a key determinant of oxygen delivery. Low cardiac output syndrome (LCOS) causes...Read more
2022 14 Oct
An overview of the clinical evidence demonstrating the effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter with heart failure and effective heart rate control during arrhythmias. Supraventricular arrhythmias (SVTs) are common in post-operative and cardiac ICUs. SVTs increase the risk of death...Read more
2022 28 Apr
Speakers Thomas Metkus, MD Divisions of Cardiology and Cardiac Surgery, Departments of Medicine and Surgery Johns Hopkins University School of Medicine Dennis Begos, MD, FACS, FACRS Medical Director, Medical and Scientific Affairs...Read more
2020 23 Apr
Atrial fibrillation (AF) is the most common heartbeat irregularity and associated with development of stroke, myocardial infarction and heart failure. Vice versa, the structural and neurohormonal changes in heart failure (HF), when the contractility of the heart muscle is reduced, make the development and progression of AF much more likely. HF itself...Read more
2019 14 Mar
The paper highlights the present clinical rationale for extravascular lung water measurement as a key to personalisation of haemodynamic therapy. Introduction Extravascular lung water (EVLW) remains a useful guide for monitoring pulmonary oedema (PO) and vascular permeability in sepsis, acute respiratory distress syndrome (ARDS),...Read more
2017 03 Oct
Researchers in Spain have developed a new tool to better assess risk of mortality from heart failure. The simple tool makes use of readily available data to accurately estimate the 30-day mortality risk for patients admitted to the emergency department with acute heart failure, according to a study published in Annals of Internal Medicine. Emergency...Read more
2017 22 Jan
Readmissions due to sepsis are higher and costlier than for the four conditions already reported in the U.S. to measure quality of care and guide pay for performance, according to researchers from the University of Pittsburgh School of Medicine and VA Pittsburgh Healthcare System. Their research is published in JAMA to coincide with the presentation...Read more
2016 30 Nov
Cardiac biomarkers, including natriuretic peptides and troponins, have become widely used in the treatment of heart failure and acute coronary syndrome. As we learn more about the function of these markers, their use has begun to expand. We can now track and utilise natriuretic peptides throughout hospital admission to monitor progress of heart failure...Read more
2015 10 Jul
A new UCLA study reveals that between 2009-2011 sepsis accounted for roughly the same percentage of hospital readmissions in California as heart attacks and congestive heart failure (CHF) — and that it cost the healthcare system more than both of them combined. Annual cost of sepsis-related readmissions in California during the study period was estimated...Read more
2015 20 May
Severe sepsis is a significant cause of rehospitalisation along the lines of nationally recognised outcome measures and more commonly discussed conditions such as pneumonia and heart failure (HF), according to a new study presented at the 2015 American Thoracic Society International Conference. “Severe sepsis continues to be a common cause of hospitalisation...Read more
2015 25 Mar
A life-support technology called ECMO that takes over for the failing hearts and lungs of critically ill patients saves lives. However, a new study has found that adults treated with ECMO were less likely to die when they were treated at hospitals caring for more ECMO patients per year. That is the key finding of the first large study in patients of...Read more